Bullous impetigo is a bacterial skin infection caused by Staphylococcus aureus that results in the formation of large blisters called bullae, usually in areas with skin folds like the armpit, groin, between the fingers or toes, beneath the breast, and between the buttocks. It accounts for 30% of cases of impetigo, the other 70% being non-bullous impetigo.The bullae are caused by exfoliative toxins produced by Staphylococcus aureus that cause the connections between cells in the uppermost layer of the skin to fall apart. Bullous impetigo in newborns, children, or adults who are immunocompromised and/or are experiencing kidney failure, can develop into a more severe and generalized form called staphylococcal scalded skin syndrome (SSSS). The mortality rate is less than 3% for infected children, but up to 60% in adults. Signs and symptoms
Bullous impetigo can appear around the diaper region, axilla, or neck. The bacteria causes a toxin to be produced that reduces cell-to-cell stickiness (adhesion), causing for the top layer of skin (epidermis), and lower layer of skin (dermis) to separate. Vesicles rapidly enlarge and form the bullae which is a blister more than 5mm across. Bullae is also known as staphylococcal scalded skin syndrome. Other associated symptoms are itching, swelling of nearby glands, fever and diarrhea. Pain is very rare.Long-term effects: once the scabs on the bullous have fallen off, scarring is minimal. Possible long-term  effects are kidney disease.
Miconazole crystallises as colourless prisms in the monoclinic space group P21/c. Other uses
Miconazole is also used in Ektachrome film developing in the final rinse of the Kodak E-6 process and similar Fuji CR-56 process, replacing formaldehyde. Fuji Hunt also includes miconazole as a final rinse additive in their formulation of the C-41RA rapid access color negative developing process. Brands and formulations
Oral treatment: (brand names Daktarin in UK, Fungimin Oral Gel in Bangladesh):

Oral gel 24 mg/ml (20 mg/g)
Oravig 50 mg once daily buccal tablet:In 2010, the U.S. Food and Drug Administration approved Oravig (miconazole) buccal tablets once daily for the local treatment of oropharyngeal candidiasis, more commonly known as thrush, in adults and children age 16 and older. Oravig is the only local, oral prescription formulation of miconazole approved for this use in the U.S.External skin treatment (brand names Desenex and Zeasorb in US and Canada, Micatin, Monistat-Derm, Daktarin in India, UK, Australia, Belgium and the Philippines, Daktar in Norway, Fungidal in Bangladesh, Decocort in Malaysia)

Topical cream: 2-5%
Combination: hydrocortisone/miconazole cream with 1% and 2%, respectively (Daktacort in UK, Daktodor in Greece)
Dusting powder: 2% powder with chlorhexidine hydrochloride (mycoDust)Vaginal treatment (brand names Miconazex, Monistat, Femizol or Gyno-Daktarin in UK):

Pessaries: 200 or 100 mg
Vaginal cream: 2% (7-day treatment), 4% (3-day treatment)
Combination:  2% cream with either 100 or 200 mg

References
External links
Kodak process E6 Ektachrome (color transparency) processing manual Z-119
Kodak process E6 Q-LAB processing manual Z-6 (more details than processing manual Z119 above)
"Miconazole". Drug Information Portal. U.S. National Library of Medicine.